Consequently, several biomarkers have been reported to reflect the link between inflammation and cancer, such as interferon-gamma/interleukin-4 ratio [28] and inflammation-based prognostic score (Glasgow prognostic score) based on CRP and albumin levels [30]. This evidence concerns the gene ALB and cancer.